These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36454562)

  • 1. The New US National Biodefense Strategy-Necessary but Not Sufficient.
    Lurie N; Sharfstein JM
    JAMA Health Forum; 2022 Dec; 3(12):e225206. PubMed ID: 36454562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From biodefence to biosecurity: the Obama administration's strategy for countering biological threats.
    Koblentz GD
    Int Aff; 2012; 88(1):131-48. PubMed ID: 22400153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reforms Needed to Modernize the US Food and Drug Administration's Oversight of Dietary Supplements, Cosmetics, and Diagnostic Tests.
    Gottlieb S; McClellan MB
    JAMA Health Forum; 2022 Oct; 3(10):e224449. PubMed ID: 36227587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blind spots in biodefense.
    Linder A; Jamieson D
    Science; 2023 Feb; 379(6633):621. PubMed ID: 36795833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bolstering FDA Pathways for Reducing Death and Disease from Tobacco.
    Gottlieb S; McClellan MB
    JAMA Health Forum; 2024 Apr; 5(4):e241233. PubMed ID: 38602704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satellites Can Help Us Fight Climate Change: Landsat data will shape the Biden administration's climate change plans.
    Haaland D
    Sci Am; 2023 Jan; 328(1):9. PubMed ID: 39017091
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacist responsiveness and readiness for oral antivirals for COVID-19: A rebuttal to the AMA statement regarding the Biden administration's test-to-treat plan.
    Hughes DM; Mordino J
    J Am Pharm Assoc (2003); 2022; 62(4):1162-1164. PubMed ID: 35450832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care in the Biden Administration's First 100 Days.
    Shafer PR; Huberfeld N
    JAMA Health Forum; 2020 Dec; 1(12):e201500. PubMed ID: 36218476
    [No Abstract]   [Full Text] [Related]  

  • 9. A Closer Look at the Biden Administration's Executive Order on Artificial Intelligence: Implications for the Imaging Space.
    Gowda V; Dreyer K; Bizzo B
    J Am Coll Radiol; 2024 Apr; ():. PubMed ID: 38679152
    [No Abstract]   [Full Text] [Related]  

  • 10. The Biden Administration's Proposal for an Advanced Research Projects Agency for Health.
    Adashi EY; Cohen IG
    JAMA Health Forum; 2021 Oct; 2(10):e212972. PubMed ID: 36218894
    [No Abstract]   [Full Text] [Related]  

  • 11. The Biden administration's unfulfilled promise of humane border policies.
    Morris JE; Saadi A
    Lancet; 2022 May; 399(10340):2013. PubMed ID: 35644152
    [No Abstract]   [Full Text] [Related]  

  • 12. Incentives for biodefense countermeasure development.
    Matheny J; Mair M; Mulcahy A; Smith BT
    Biosecur Bioterror; 2007 Sep; 5(3):228-38. PubMed ID: 17903091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biden Administration's Immigration Policies and the Impact on School Health-A Commentary.
    Dorsainvil M
    J Sch Health; 2021 Jul; 91(7):523-525. PubMed ID: 34031887
    [No Abstract]   [Full Text] [Related]  

  • 14. Harmony between Man and His Environment: Reviewing the Trump Administration's Changes to the National Environmental Policy Act in the Context of Environmental Racism.
    Kolencik GM
    J Law Med Ethics; 2022; 50(1):76-84. PubMed ID: 35243991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling and simulation in dose determination for biodefense products approved under the FDA animal rule.
    Bergman KL; Krudys K; Seo SK; Florian J
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):153-160. PubMed ID: 28299529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing nursing research opportunities in biodefense: National Institute of Nursing Research Science workgroup.
    Sigmon HD; Larson EL
    Biol Res Nurs; 2003 Apr; 4(4):306-10. PubMed ID: 12698923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kenneth W. Kizer on a national quality strategy. Interview by Lori Blades and Patricia A. Cholewka.
    Kizer KW
    J Healthc Qual; 2000; 22(5):19-22. PubMed ID: 11184023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological threat characterization research: a critical component of national biodefense.
    Petro JB; Carus WS
    Biosecur Bioterror; 2005; 3(4):295-308. PubMed ID: 16366839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The US Food and Drug Administration's tentative approval process and the global fight against HIV.
    Chahal HS; Murray JS; Shimer M; Capella P; Presto R; Valdez ML; Lurie PG
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29232052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research opportunities in biodefense for the National Institute of Nursing Research.
    Sigmon HD; Larson EL
    Am J Infect Control; 2002 Dec; 30(8):490-4. PubMed ID: 12461512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.